Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells.
Hamaya S, Fujihara S, Iwama H, Fujita K, Shi T, Nakabayashi R, Mizuo T, Takuma K, Nakahara M, Oura K, Tadokoro T, Mimura S, Tani J, Morishita A, Kobara H, Ono M, Himoto T, Masaki T.
Hamaya S, et al. Among authors: shi t.
Anticancer Res. 2022 Mar;42(3):1263-1275. doi: 10.21873/anticanres.15593.
Anticancer Res. 2022.
PMID: 35220216